News About: Pharm. Industry
Daewoong takes a lead for anticancer ‘Samfenet’ on behalf of Samsung Bioepis
Daewoong Pharmaceutical(CEO Jong-Wook Lee) announced the company would launch ‘Samfenet,’ a Samsung Bioepis’ trastuzumab biosimilar on the 5th in Korea. Samfenet acquired approval from the Korean Ministry of Food and ...
“Korean pharmaceutical industry with mobility will join ‘AI soceity’”
It was anticipated the Korean pharmaceutical industry might be able to become one of the advanced pharmaceutical power in developing new drugs using AI(artificial intelligence) with their strong point called ‘mobility...
U.S. FDA starts to review NDA of SK Biopharmaceuticals’ new sleep disorder treatment
SK Biopharmaceuticals(CEO Jung-Woo Cho) announced the company completed the New Drug Application(NDA) of SKL-N05(generic name: solriamfetol) that is being jointly developed with Jazz Pharmaceuticals, the world’s top p...
AstraZeneca signs partnership of Foxiga and Xigduo with Daewoong Pharmaceutical
AstraZeneca Korea(CEO/President Sang-Pyo Kim) announced the company established a distribution partnership of ‘Forxiga(dapagliflozin)’ and ‘Xigduo(dapagliflozin/metformin),’ SGLT-2 inhibitors for the treatment of hepa...
The amount paid in dividends pharmaceutical companies will pay more than KRW 220 billion this year
The amount paid in dividends pharmaceutical companies will distribute this year are expected will be much more than the last year’s amount, which is about KRW 220 billion.
According to the Yakup Shinmoon’s(www.yakup....
Highly interested in getting jackpots on GC Pharm, Daewoong and Hanmi this year
Our journal had a relay of interviews with major pharmaceutical companies’ CEOs in the beginning of 2018. Through these interviews, we thoroughly observed their new year resolutions, future visions and strategies for ...
Huons Global founds ‘Huons Lab’ specializing in bio-R&D
In order to achieve the goal to strengthen its R&D capability as to become a leading company in the biotechnology field, Huons Global(CEO Sung-Tae Yoon & Wan-Sup Kim) announced a decision to found Huons Lab on the 27t...
KPBMA founds Council of the A.I. New Drug Developing Support Center
The Korea Pharmaceutical and Bio-Pharma Manufacturers Association’s(KPBMA) Council of the A.I. New Drug Development Support Center will be founded.
The council will hold a foundation ceremony in the 2nd floor of the ...
Whan In Pharm signs exclusive agreement of introducing the epilepsy treatment ‘Zebinix’
Whan In Pharm(CEO Won-Bum Lee) signed an exclusive license agreement of ‘Zebinix,’ an epilepsy treatment developed by Portuguese Bial(CEO António Portela), in Korea at the headquarters on the 26th.
‘Zebinix,’ a once-...
Sam Chun Dang Pharm to sign eye drop export agreements of more than KRW 1 trillion in U.S. and Europe
Sam Chun Dang Pharm has drawn attention of the industry as signing export agreements of its eye drops to advanced markets, like the U.S. and Europe. There are three reasons why this is.
According to Sam Chun Dang Pha...
